↓ Skip to main content

Cost Effectiveness of Budesonide/Formoterol Added to Tiotropium Bromide versus Placebo Added to Tiotropium Bromide in Patients with Chronic Obstructive Pulmonary Disease

Overview of attention for article published in PharmacoEconomics, December 2012
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age

Mentioned by

policy
1 policy source

Citations

dimensions_citation
22 Dimensions

Readers on

mendeley
50 Mendeley
Title
Cost Effectiveness of Budesonide/Formoterol Added to Tiotropium Bromide versus Placebo Added to Tiotropium Bromide in Patients with Chronic Obstructive Pulmonary Disease
Published in
PharmacoEconomics, December 2012
DOI 10.2165/11590380-000000000-00000
Pubmed ID
Authors

Nicole Mittmann, Paul Hernandez, Carl Mellström, Lance Brannman, Tobias Welte

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 50 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 2 4%
Unknown 48 96%

Demographic breakdown

Readers by professional status Count As %
Researcher 9 18%
Student > Master 8 16%
Student > Postgraduate 6 12%
Student > Ph. D. Student 4 8%
Student > Doctoral Student 3 6%
Other 9 18%
Unknown 11 22%
Readers by discipline Count As %
Medicine and Dentistry 20 40%
Nursing and Health Professions 6 12%
Economics, Econometrics and Finance 4 8%
Biochemistry, Genetics and Molecular Biology 2 4%
Pharmacology, Toxicology and Pharmaceutical Science 2 4%
Other 5 10%
Unknown 11 22%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 22 October 2019.
All research outputs
#8,534,976
of 25,374,647 outputs
Outputs from PharmacoEconomics
#996
of 1,992 outputs
Outputs of similar age
#88,136
of 289,102 outputs
Outputs of similar age from PharmacoEconomics
#95
of 280 outputs
Altmetric has tracked 25,374,647 research outputs across all sources so far. This one is in the 43rd percentile – i.e., 43% of other outputs scored the same or lower than it.
So far Altmetric has tracked 1,992 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 7.6. This one is in the 25th percentile – i.e., 25% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 289,102 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 43rd percentile – i.e., 43% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 280 others from the same source and published within six weeks on either side of this one. This one is in the 10th percentile – i.e., 10% of its contemporaries scored the same or lower than it.